These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9262035)

  • 1. Comparison of a once-a-day sustained-release morphine formulation with standard oral morphine treatment for cancer pain.
    Broomhead A; Kerr R; Tester W; O'Meara P; Maccarrone C; Bowles R; Hodsman P
    J Pain Symptom Manage; 1997 Aug; 14(2):63-73. PubMed ID: 9262035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of twenty-four-hourly Kapanol compared to twelve-hourly MS Contin in the treatment of severe cancer pain.
    Gourlay GK; Cherry DA; Onley MM; Tordoff SG; Conn DA; Hood GM; Plummer JL
    Pain; 1997 Feb; 69(3):295-302. PubMed ID: 9085304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and clinical efficacy of oral morphine solution and controlled-release morphine tablets in cancer patients.
    Thirlwell MP; Sloan PA; Maroun JA; Boos GJ; Besner JG; Stewart JH; Mount BM
    Cancer; 1989 Jun; 63(11 Suppl):2275-83. PubMed ID: 2720576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a cancer pain model for the testing of long-acting analgesics. The effect of MS Contin in a double-blind, randomized crossover design.
    Cundiff D; McCarthy K; Savarese JJ; Kaiko R; Thomas G; Grandy R; Goldenheim P
    Cancer; 1989 Jun; 63(11 Suppl):2355-9. PubMed ID: 2720581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analgesic response to single and multiple doses of controlled-release morphine tablets and morphine oral solution in cancer patients.
    Goughnour BR; Arkinstall WW; Stewart JH
    Cancer; 1989 Jun; 63(11 Suppl):2294-7. PubMed ID: 2720578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy and safety of once-daily dosing of a novel, prolonged-release oral morphine tablet compared with twice-daily dosing of a standard controlled-release morphine tablet in patients with cancer pain: a randomized, double-blind, exploratory crossover study.
    Ridgway D; Sopata M; Burneckis A; Jespersen L; Andersen C
    J Pain Symptom Manage; 2010 Apr; 39(4):712-20. PubMed ID: 20413058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral controlled-release morphine sulfate. Analgesic efficacy and side effects of a 100-mg tablet in cancer pain patients.
    Portenoy RK; Maldonado M; Fitzmartin R; Kaiko RF; Kanner R
    Cancer; 1989 Jun; 63(11 Suppl):2284-8. PubMed ID: 2720577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The United States experience with oral controlled-release morphine (MS Contin tablets). Parts I and II. Review of nine dose titration studies and clinical pharmacology of 15-mg, 30-mg, 60-mg, and 100-mg tablet strengths in normal subjects.
    Kaiko RF; Grandy RP; Oshlack B; Pav J; Horodniak J; Thomas G; Ingber E; Goldenheim PD
    Cancer; 1989 Jun; 63(11 Suppl):2348-54. PubMed ID: 2720580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of severe pain with sustained-release morphine tablets v. oral morphine solution.
    Arkinstall WW; Goughnour BR; White JA; Stewart JH
    CMAJ; 1989 Mar; 140(6):653-7, 661. PubMed ID: 2645988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained relief of chronic pain. Pharmacokinetics of sustained release morphine.
    Gourlay GK
    Clin Pharmacokinet; 1998 Sep; 35(3):173-90. PubMed ID: 9784932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer pain management with a controlled-release oral morphine preparation.
    Lapin J; Houde RW; Kaiko RF; Coyle N; Rogers A; Foley KM
    J Pain Symptom Manage; 1989 Sep; 4(3):146-51. PubMed ID: 2778362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR).
    Coluzzi PH; Schwartzberg L; Conroy JD; Charapata S; Gay M; Busch MA; Chavez J; Ashley J; Lebo D; McCracken M; Portenoy RK
    Pain; 2001 Mar; 91(1-2):123-30. PubMed ID: 11240084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy, safety and pharmacokinetics of a newly developed controlled release morphine sulphate suppository in patients with cancer pain.
    Moolenaar F; Meijler WJ; Frijlink HW; Visser J; Proost JH
    Eur J Clin Pharmacol; 2000 Jun; 56(3):219-23. PubMed ID: 10952476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting dosing regimens of morphine sulfate extended-release (KADIAN) capsules.
    Weil AJ; Nicholson B; Sasaki J
    J Opioid Manag; 2009; 5(1):39-45. PubMed ID: 19344047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
    Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA
    Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of regularly administered sustained release oral morphine with intramuscular morphine for control of postoperative pain.
    Bourke M; Hayes A; Doyle M; McCarroll M
    Anesth Analg; 2000 Feb; 90(2):427-30. PubMed ID: 10648333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of analgesia in human chronic pain. Randomized double-blind crossover study of once daily repro-dose morphine versus MST continus.
    Peat S; Sweet P; Miah Y; Barklamb M; Larsen U
    Eur J Clin Pharmacol; 1999 Oct; 55(8):577-81. PubMed ID: 10541775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placebo-blinded study of morphine sulfate sustained-release tablets and immediate-release morphine sulfate solution in outpatients with chronic pain due to advanced cancer.
    Finn JW; Walsh TD; MacDonald N; Bruera E; Krebs LU; Shepard KV
    J Clin Oncol; 1993 May; 11(5):967-72. PubMed ID: 8487059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of sustained release morphine hydrochloride tablets in management of cancer pain: a survey of 567 patients].
    Yu SY; Qiu H; Ma ZS; Chen J; Zhang Y; Chen LZ; Wang DL; Ma ZY
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(6):450-5. PubMed ID: 15061959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetics of PF-402, sustained-release morphine capsule, in cancer patients with pain].
    Ogawa H; Hiraga K; Takeda F
    Masui; 1998 Jul; 47(7):817-23. PubMed ID: 9720327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.